Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
HCM III Acquisition Corp. is a special purpose acquisition company (SPAC) formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more operating businesses. The company does not conduct operating activities and does not generate revenue from commercial operations; its primary function is capital deployment through an acquisition. As a blank-check company, its value proposition is tied to its management team’s sourcing, evaluation, and execution of a suitable business combination.
The company was incorporated in 2021 and completed its initial public offering with the intent to identify a target business primarily in the healthcare, life sciences, or healthcare technology sectors, although it is not contractually limited to these industries. Since inception, activities have focused on IPO proceeds management, regulatory compliance, and target evaluation. As of the most recent public disclosures, the company has not completed a business combination, and its future operations are contingent on consummating such a transaction within the timeframe specified in its SEC filings.
Business Operations
HCM III Acquisition Corp.’s operations are limited to administrative functions, trust account management, and the evaluation of potential acquisition targets. IPO proceeds are held in a trust account and invested in permitted short-term instruments until either a business combination is completed or the company is liquidated. The company does not have operating segments, customers, proprietary technology, or revenue-producing assets.
The company’s structure includes sponsor-controlled entities that provide management services and working capital through promissory notes or private placement warrants. There are no material subsidiaries with independent operations, and no joint ventures or strategic partnerships have been disclosed beyond standard SPAC sponsor arrangements. All operational expenditures relate to legal, accounting, due diligence, and regulatory costs.
Strategic Position & Investments
The strategic objective of HCM III Acquisition Corp. is to acquire a single operating company that can benefit from access to public capital markets and the experience of its sponsor and management team. Target selection criteria emphasize scalable business models, defensible market positions, and management teams capable of long-term value creation, consistent with disclosures in its registration statements and periodic reports.
The company has not completed any acquisitions or equity investments to date. Aside from the placement of IPO proceeds into the trust account, there are no operating investments, portfolio companies, or exposure to emerging technologies through ownership or control. Any future strategic positioning is dependent on the successful identification and completion of a qualifying business combination. Data inconclusive based on available public sources regarding any definitive acquisition targets.
Geographic Footprint
HCM III Acquisition Corp. is headquartered in the United States, with its legal domicile and administrative operations located domestically. The company does not maintain offices, employees, or operating facilities outside of its principal executive location.
While its search for a business combination target is not geographically restricted, no international operations or investments have been established. Any future global footprint would be determined by the location and scope of the acquired business following a completed transaction.
Leadership & Governance
The company is sponsored by an affiliate of HCM, a healthcare-focused investment firm, and is governed by a board of directors and executive officers responsible for acquisition strategy, fiduciary oversight, and regulatory compliance. Governance follows standard SPAC practices, including audit and compensation committee oversight in accordance with public company requirements.
Key executives and directors include:
- Michael E. McMahan – Chief Executive Officer and Chairman
- Paul R. Anderson – Chief Financial Officer
- Robert W. Duggan – Director
- Lisa A. Conte – Director
Leadership emphasizes disciplined capital allocation, sector-specific expertise, and adherence to public market governance standards, with strategic vision centered on identifying a value-accretive business combination within the healthcare ecosystem.